BioAnalysis, LLC

About BioAnalysis, LLC

This startup operates a non-clinical Contract Research Organization (CRO) specializing in biophysics and mass spectrometry for gene therapy and biotherapeutics. By providing scientifically rigorous analyses of monoclonal antibodies, therapeutic proteins, antibody-drug conjugates, and nanoparticles, the company delivers precise insights that enhance the development of these complex therapeutic candidates.

```xml <problem> The development of gene therapies and biotherapeutics requires rigorous analytical testing to ensure product quality, safety, and efficacy. Traditional contract research organizations (CROs) may suffer from poor data quality and long turnaround times, hindering timely decision-making and slowing down the drug development process. </problem> <solution> BioAnalysis is a non-clinical collaborative research organization (CRO) specializing in biophysics and mass spectrometry, providing high-quality analytical services for gene therapy, biotherapeutics, and the broader life science industries. The company offers comprehensive GMP and non-GMP testing services, including analytical ultracentrifugation (AUC), liquid chromatography-mass spectrometry (LCMS), high-performance liquid chromatography (HPLC), and dynamic light scattering (DLS). BioAnalysis focuses on delivering accurate data and analyses with industry-leading turnaround times, enabling clients to accelerate drug development from discovery to commercialization. Their commitment to client engagement and scientific expertise ensures that clients receive tailored solutions and support throughout the entire process. </solution> <features> - Analytical Ultracentrifugation (AUC) for determining gene therapy vector incorporation, detecting aggregates, and assessing size distribution of lipid nanoparticles and monoclonal antibodies. - Liquid Chromatography-Mass Spectrometry (LCMS) for protein identification, post-translational modification (PTM) analysis, peptide mapping, intact mass assessment, and host cell protein (HCP) analysis. - High-Performance Liquid Chromatography (HPLC) for characterization, identification, and quantification of drug products and excipients, as well as purity and impurity testing. - Dynamic Light Scattering (DLS) for aggregation and particle size determination. - GMP-compliant assays for AUC, HPLC, DLS, and LCMS technologies. - Capabilities for analyzing therapeutic mRNAs, guide RNAs, lipid nanoparticles (LNPs), and vaccines. - Expertise in Size Exclusion Chromatography (SEC), Reverse Phase (RP), Ion Exchange (IEX), and Hydrophilic Interaction (HILIC). </features> <target_audience> BioAnalysis serves gene therapy and biotherapeutic companies, as well as other life science organizations, requiring analytical testing services to support drug development, manufacturing, and quality control. </target_audience> ```

What does BioAnalysis, LLC do?

This startup operates a non-clinical Contract Research Organization (CRO) specializing in biophysics and mass spectrometry for gene therapy and biotherapeutics. By providing scientifically rigorous analyses of monoclonal antibodies, therapeutic proteins, antibody-drug conjugates, and nanoparticles, the company delivers precise insights that enhance the development of these complex therapeutic candidates.

Where is BioAnalysis, LLC located?

BioAnalysis, LLC is based in Philadelphia, United States.

When was BioAnalysis, LLC founded?

BioAnalysis, LLC was founded in 2017.

How much funding has BioAnalysis, LLC raised?

BioAnalysis, LLC has raised $4.4M.

Location
Philadelphia, United States
Founded
2017
Funding
$4.4M
Employees
27 employees
BL

BioAnalysis, LLC

This startup operates a non-clinical Contract Research Organization (CRO) specializing in biophysics and mass spectrometry for gene therapy and biotherapeutics. By providing scientifically rigorous analyses of monoclonal antibodies, therapeutic proteins, antibody-drug conjugates, and nanoparticles, the company delivers precise insights that enhance the development of these complex therapeutic candidates.

Philadelphia, United StatesFounded 2017272K+ followers6/10 TractionRelative Traction Score based on online presence metrics compared to companies in the same age group.
Updated 2 months ago

Funding

$4.4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Product

Problem

The development of gene therapies and biotherapeutics requires rigorous analytical testing to ensure product quality, safety, and efficacy. Traditional contract research organizations (CROs) may suffer from poor data quality and long turnaround times, hindering timely decision-making and slowing down the drug development process.

Solution

BioAnalysis is a non-clinical collaborative research organization (CRO) specializing in biophysics and mass spectrometry, providing high-quality analytical services for gene therapy, biotherapeutics, and the broader life science industries. The company offers comprehensive GMP and non-GMP testing services, including analytical ultracentrifugation (AUC), liquid chromatography-mass spectrometry (LCMS), high-performance liquid chromatography (HPLC), and dynamic light scattering (DLS). BioAnalysis focuses on delivering accurate data and analyses with industry-leading turnaround times, enabling clients to accelerate drug development from discovery to commercialization. Their commitment to client engagement and scientific expertise ensures that clients receive tailored solutions and support throughout the entire process.

Target Audience

BioAnalysis serves gene therapy and biotherapeutic companies, as well as other life science organizations, requiring analytical testing services to support drug development, manufacturing, and quality control.

Features

  • Analytical Ultracentrifugation (AUC) for determining gene therapy vector incorporation, detecting aggregates, and assessing size distribution of lipid nanoparticles and monoclonal antibodies.
  • Liquid Chromatography-Mass Spectrometry (LCMS) for protein identification, post-translational modification (PTM) analysis, peptide mapping, intact mass assessment, and host cell protein (HCP) analysis.
  • High-Performance Liquid Chromatography (HPLC) for characterization, identification, and quantification of drug products and excipients, as well as purity and impurity testing.
  • Dynamic Light Scattering (DLS) for aggregation and particle size determination.
  • GMP-compliant assays for AUC, HPLC, DLS, and LCMS technologies.
  • Capabilities for analyzing therapeutic mRNAs, guide RNAs, lipid nanoparticles (LNPs), and vaccines.
  • Expertise in Size Exclusion Chromatography (SEC), Reverse Phase (RP), Ion Exchange (IEX), and Hydrophilic Interaction (HILIC).
1
This profile is AI-generated and may contain inaccuracies.